ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,000 | -89.2% | 300 | -86.4% | 0.00% | – |
Q3 2018 | $37,000 | -2.6% | 2,200 | -8.3% | 0.00% | – |
Q2 2018 | $38,000 | +31.0% | 2,400 | -4.0% | 0.00% | – |
Q4 2017 | $29,000 | -94.0% | 2,500 | -94.1% | 0.00% | -100.0% |
Q2 2017 | $486,000 | -40.9% | 42,416 | +7.2% | 0.00% | -50.0% |
Q1 2017 | $823,000 | +146.4% | 39,579 | +145.2% | 0.00% | +100.0% |
Q4 2016 | $334,000 | – | 16,142 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |